Clinical Trial

Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Glaucoma is a complex disease that can result in progressive vision loss. It is the second leading cause of blindness, accounting for 23% of permanent blindness in Hong Kong. There are no treatments that restore vision lost to glaucoma. This study will examine the effect of transcranial direct current stimulation (NIBS) on improving quality of life, visual function and functional performance in patients with peripheral field loss due to glaucoma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-17.
Trial Details
NCT Number NCT07486323
Lead Sponsor The Hong Kong Polytechnic University
Conditions Glaucoma Open-Angle
Enrollment 56 participants
Start Date 2026-04-20
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-24